Parametric Portfolio Associates’s AnaptysBio ANAB Stock Holding History

Parametric Portfolio Associates’s Portfolio ANAB Stock Details ANAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	$1.33M	Sell	53,963 -794	-1%	-$24K	﹤0.01%	2641
2021 Q4	$1.9M	Sell	54,757 -2,522	-4%	-$80K	﹤0.01%	2463
2021 Q3	$1.55M	Buy	57,279 +6,544	+13%	+$166K	﹤0.01%	2574
2021 Q2	$1.32M	Sell	50,735 -3,203	-6%	-$76.8K	﹤0.01%	2653
2021 Q1	$1.16M	Buy	53,938 +7,003	+15%	+$177K	﹤0.01%	3093
2020 Q4	$1.01M	Buy	46,935 +9,647	+26%	+$234K	﹤0.01%	3047
2020 Q3	$550K	Buy	37,288 +3,827	+11%	+$69K	﹤0.01%	3225
2020 Q2	$748K	Sell	33,461 -14,416	-30%	-$264K	﹤0.01%	3075
2020 Q1	$677K	Buy	47,877 +10,988	+30%	+$167K	﹤0.01%	2999
2019 Q4	$599K	Buy	36,889 +28,063	+318%	+$664K	﹤0.01%	3303
2019 Q3	$309K	Buy	8,826 +3,112	+54%	+$148K	﹤0.01%	3518
2019 Q2	$322K	Buy	+5,714	New	+$411K	﹤0.01%	3549
2018 Q4	–	Sell	-2,032	Closed	-$203K	–	3903
2018 Q3	$203K	Buy	+2,032	New	+$169K	﹤0.01%	3754

Other funds holding ANAB

EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

FLSM

Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Parametric Portfolio Associates's ANAB Position: Q1 2022 in Review

Parametric Portfolio Associates reduced its AnaptysBio (ANAB) stake by 1.5% in Q1 2022, selling an estimated $24K and leaving 53,963 shares worth $1.33M. The position accounts for ﹤0.01% of the portfolio, ranked #2641.

Parametric Portfolio Associates first reported a position in ANAB in Q3 2018 and has held it in 13 quarters since. The position peaked at $1.9M in Q4 2021. 132 funds tracked by Wall St. Rank hold ANAB as of Q1 2022.

Parametric Portfolio Associates held 53,963 shares of AnaptysBio worth $1.33M as of Q1 2022.
Parametric Portfolio Associates sold 794 AnaptysBio shares in Q1 2022, an estimated $24K.
AnaptysBio made up ﹤0.01% of Parametric Portfolio Associates's portfolio in Q1 2022, its #2641 holding.
Parametric Portfolio Associates first reported a position in AnaptysBio in Q3 2018 and has held it in 13 quarters since.
Parametric Portfolio Associates's AnaptysBio position peaked at $1.9M in Q4 2021.
132 funds tracked by Wall St. Rank held AnaptysBio as of Q1 2022.

Based on Parametric Portfolio Associates's 13F filing for Q1 2022, filed 16 May 2022.